{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:41Z","timestamp":1790985221881,"version":"4.1.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-026-00946-8","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:11:33Z","timestamp":1790925093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences\u2014a scoping review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9847-011X","authenticated-orcid":false,"given":"Nishanth","family":"Gowda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravan","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"946_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911847","author":"D Mart\u00ednez-Rubio","year":"2022","unstructured":"Mart\u00ednez-Rubio D, Hinarejos I, Sancho P, Gorr\u00eda-Redondo N, Bernad\u00f3-Fonz R, Tello C et al (2022) Mutations, genes, and phenotypes related to movement disorders and ataxias. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911847","journal-title":"Int J Mol Sci"},{"key":"946_CR2","doi-asserted-by":"publisher","unstructured":"Founder variants and population genomes\u2014Toward precision medicine. In: Advances in Genetics [Internet]. Elsevier (2021) [cited 2026 Jun 14]. pp. 121\u201352. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065266020300432https:\/\/doi.org\/10.1016\/bs.adgen.2020.11.004","DOI":"10.1016\/bs.adgen.2020.11.004"},{"issue":"Pt 1","key":"946_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1469-1809.1999.6310001.x","volume":"63","author":"EM Valente","year":"1999","unstructured":"Valente EM, Povey S, Warner TT, Wood NW, Davis MB (1999) Detailed haplotype analysis in Ashkenazi Jewish and non-Jewish British dystonic patients carrying the GAG deletion in the DYT1 gene: evidence for a limited number of founder mutations. Ann Hum Genet 63(Pt 1):1\u20138. https:\/\/doi.org\/10.1046\/j.1469-1809.1999.6310001.x","journal-title":"Ann Hum Genet"},{"key":"946_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2016.00071","volume":"7","author":"N Giladi","year":"2016","unstructured":"Giladi N, Mirelman A, Thaler A, Orr-Urtreger A (2016) A personalized approach to Parkinson\u2019s disease patients based on founder mutation analysis. Front Neurol 7:71. https:\/\/doi.org\/10.3389\/fneur.2016.00071","journal-title":"Front Neurol"},{"issue":"3\u20134","key":"946_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10689-004","volume":"3","author":"J Charrow","year":"2004","unstructured":"Charrow J (2004) Ashkenazi Jewish genetic disorders. Fam Cancer 3(3\u20134):201\u2013206. https:\/\/doi.org\/10.1007\/s10689-004-9545-z PubMed PMID: 15516842","journal-title":"Fam Cancer"},{"issue":"3","key":"946_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12311-020-01109-7","volume":"19","author":"R Rodr\u00edguez-Labrada","year":"2020","unstructured":"Rodr\u00edguez-Labrada R, Martins AC, Maga\u00f1a JJ, Vazquez-Mojena Y, Medrano-Montero J, Fernandez-Ru\u00edz J et al (2020) Founder effects of spinocerebellar ataxias in the American continents and the Caribbean. Cerebellum 19(3):446\u201358. https:\/\/doi.org\/10.1007\/s12311-020-01109-7","journal-title":"Cerebellum"},{"issue":"7","key":"946_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.ejhg.5201151","volume":"12","author":"MPA Zeegers","year":"2004","unstructured":"Zeegers MPA, van Poppel F, Vlietinck R, Spruijt L, Ostrer H (2004) Founder mutations among the Dutch. Eur J Hum Genet EJHG 12(7):591\u2013600. https:\/\/doi.org\/10.1038\/sj.ejhg.5201151 PubMed PMID: 15010701","journal-title":"Eur J Hum Genet EJHG"},{"issue":"10","key":"946_CR8","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L et al (2020) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 18(10):2119\u20132126. https:\/\/doi.org\/10.11124\/JBIES-20-00167","journal-title":"JBI Evid Synth"},{"issue":"1","key":"946_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00439-005-1278-z","volume":"117","author":"DS Verbeek","year":"2005","unstructured":"Verbeek DS, van de Warrenburg BPC, Hennekam FAM, Dooijes D, Ippel PF, Verschuuren-Bemelmans CC et al (2005) Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. Hum Genet 117(1):88\u201391. https:\/\/doi.org\/10.1007\/s00439-005-1278-z","journal-title":"Hum Genet"},{"key":"946_CR10","doi-asserted-by":"publisher","first-page":"117082","DOI":"10.1016\/j.jns.2020.117082","volume":"417","author":"SS Scott","year":"2020","unstructured":"Scott SS, de O, Pedroso JL, Barsottini OGP, Fran\u00e7a-Junior MC, Braga-Neto P (2020) Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays. J Neurol Sci 417:117082. https:\/\/doi.org\/10.1016\/j.jns.2020.117082 PubMed PMID: 32791425","journal-title":"J Neurol Sci"},{"issue":"1","key":"946_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1017\/s0317167100005783","volume":"34","author":"JW Cho","year":"2007","unstructured":"Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM et al (2007) The G2019S LRRK2 mutation is rare in Korean patients with Parkinson\u2019s disease. Can J Neurol Sci J Can Sci Neurol 34(1):53\u20135. https:\/\/doi.org\/10.1017\/s0317167100005783","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"946_CR12","doi-asserted-by":"publisher","unstructured":"Wu LY, Du Toit T, Georgiades T, Stafford EJ, Levine K, Fang ZH et al (2026) Pathology and genetics in a global cohort of Parkinsonian disorders. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2026.1634","DOI":"10.1001\/jamaneurol.2026.1634"},{"issue":"12","key":"946_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122673","volume":"12","author":"L Marsili","year":"2024","unstructured":"Marsili L, Duque KR, Abanto J, Chinchihualpa Paredes NO, Duker AP, Collins K et al (2024) Studying rare movement disorders: from whole-exome sequencing to new diagnostic and therapeutic approaches in a modern genetic clinic. Biomedicines 12(12):2673. https:\/\/doi.org\/10.3390\/biomedicines12122673","journal-title":"Biomedicines"},{"issue":"5","key":"946_CR14","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/mds.30150","volume":"40","author":"H Wang","year":"2025","unstructured":"Wang H, Chang TS, Dombroski BA, Cheng P, Si Y, Tucci A et al (2025) Copy Number Variation and Haplotype Analysis of 17q21.31 Reveals Increased Risk Associated with Progressive Supranuclear Palsy and Gene Expression Changes in Neuronal Cells. Mov Disord 40(5):950\u2013961. https:\/\/doi.org\/10.1002\/mds.30150","journal-title":"Mov Disord"},{"key":"946_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2021.04.024","volume":"87","author":"M Amprosi","year":"2021","unstructured":"Amprosi M, Zech M, Lichtner P, Eckstein G, Unterberger I, Eigentler A et al (2021) The rare and the common: an Austrian DRPLA family harboring the European haplotype. Parkinsonism Relat Disord 87:119\u201321. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.04.024","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"946_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D et al (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 169(7):467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"946_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70475","author":"J Moura","year":"2025","unstructured":"Moura J, Balint B, Cullinane P, Alhashash H, Magrinelli F, Latorre A et al (2025) Ethnic and Epidemiological Peculiarities of Movement Disorders across the World. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.70475. mdc3.70475","journal-title":"Mov Disord Clin Pract"},{"key":"946_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1216929","volume":"17","author":"Y Fan","year":"2023","unstructured":"Fan Y, Si Z, Wang L, Zhang L (2023) DYT-TOR1A dystonia: an update on pathogenesis and treatment. Front Neurosci 17:1216929. https:\/\/doi.org\/10.3389\/fnins.2023.1216929","journal-title":"Front Neurosci"},{"issue":"8","key":"946_CR19","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1093\/brain\/awad039","volume":"146","author":"A Saffari","year":"2023","unstructured":"Saffari A, Lau T, Tajsharghi H, Karimiani EG, Kariminejad A, Efthymiou S et al (2023) The clinical and genetic spectrum of autosomal-recessive TOR1A -related disorders. Brain 146(8):3273\u20133288. https:\/\/doi.org\/10.1093\/brain\/awad039","journal-title":"Brain"},{"issue":"10","key":"946_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1212\/WNL.0b013e3181d5276d","volume":"74","author":"H Houlden","year":"2010","unstructured":"Houlden H, Schneider SA, Paudel R, Melchers A, Schwingenschuh P, Edwards M et al (2010) THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology 74(10):846\u201350. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5276d","journal-title":"Neurology"},{"issue":"3","key":"946_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ng.304","volume":"41","author":"T Fuchs","year":"2009","unstructured":"Fuchs T, Gavarini S, Saunders-Pullman R, Raymond D, Ehrlich ME, Bressman SB et al (2009) Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 41(3):286\u2013288. https:\/\/doi.org\/10.1038\/ng.304","journal-title":"Nat Genet"},{"issue":"1\u20132","key":"946_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jns.2014.06.012","volume":"344","author":"FP Da Silva-Junior","year":"2014","unstructured":"Da Silva-Junior FP, Dos Santos CO, Silva SMCA, Barbosa ER, Borges V, Ferraz HB et al (2014) Novel THAP1 variants in Brazilian patients with idiopathic isolated dystonia. J Neurol Sci 344(1\u20132):190\u2013192. https:\/\/doi.org\/10.1016\/j.jns.2014.06.012","journal-title":"J Neurol Sci"},{"issue":"5","key":"946_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1474-4422(09)70081-X","volume":"8","author":"SB Bressman","year":"2009","unstructured":"Bressman SB, Raymond D, Fuchs T, Heiman GA, Ozelius LJ, Saunders-Pullman R (2009) Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 8(5):441\u20136. https:\/\/doi.org\/10.1016\/S1474-4422(09)70081-X","journal-title":"Lancet Neurol"},{"issue":"6","key":"946_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/mds.25818","volume":"29","author":"R Saunders-Pullman","year":"2014","unstructured":"Saunders-Pullman R, Fuchs T, San Luciano M, Raymond D, Brashear A, Ortega R et al (2014) Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites. Mov Disord Off J Mov Disord Soc 29(6):812\u2013818. https:\/\/doi.org\/10.1002\/mds.25818 PubMed PMID: 24500857; PubMed Central PMCID: PMC4013240","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"7","key":"946_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/brainsci7070072","volume":"7","author":"T Kawarai","year":"2017","unstructured":"Kawarai T, Morigaki R, Kaji R, Goto S (2017) Clinicopathological Phenotype and Genetics of X-Linked Dystonia\u2013Parkinsonism (XDP; DYT3; Lubag). Brain Sci 7(7):72. https:\/\/doi.org\/10.3390\/brainsci7070072","journal-title":"Brain Sci"},{"issue":"3","key":"946_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1086\/512129","volume":"80","author":"S Makino","year":"2007","unstructured":"Makino S, Kaji R, Ando S, Tomizawa M, Yasuno K, Goto S et al (2007) Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet 80(3):393\u2013406 doi:10.1086\/512129 PubMed PMID: 17273961","journal-title":"Am J Hum Genet"},{"key":"946_CR27","unstructured":"Lee LV, Munoz EL, Tan KT, Reyes MT Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP)"},{"issue":"5","key":"946_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2018.02.011","volume":"172","author":"T Aneichyk","year":"2018","unstructured":"Aneichyk T, Hendriks WT, Yadav R, Shin D, Gao D, Vaine CA et al (2018) Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly. Cell 172(5):897\u2013909e21. https:\/\/doi.org\/10.1016\/j.cell.2018.02.011 PubMed PMID: 29474918; PubMed Central PMCID: PMC5831509","journal-title":"Cell"},{"issue":"10","key":"946_CR29","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/ejhg.2014.292","volume":"23","author":"A Domingo","year":"2015","unstructured":"Domingo A, Westenberger A, Lee LV, Br\u00e6nne I, Liu T, Vater I et al (2015) New insights into the genetics of X-linked dystonia-parkinsonism (XDP, DYT3). Eur J Hum Genet 23(10):1334\u201340. https:\/\/doi.org\/10.1038\/ejhg.2014.292","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"946_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(08)70022-X","volume":"7","author":"S Camargos","year":"2008","unstructured":"Camargos S, Scholz S, Simon-Sanchez J, Paisan-Ruiz C, Lewis P, Hernandez D et al (2008) DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 7(3):207\u2013215 PubMed PMID: 18243799","journal-title":"Lancet Neurol"},{"key":"946_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.parkreldis.2017.12.015","volume":"48","author":"CO Dos Santos","year":"2018","unstructured":"Dos Santos CO, Da Silva-J\u00fanior FP, Puga RD, Barbosa ER, Azevedo Silva SMC, Borges V et al (2018) The prevalence of PRKRA mutations in idiopathic dystonia. Parkinsonism Relat Disord 48:93\u201396. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.12.015","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"946_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/10738584241257927","volume":"31","author":"D Dhar","year":"2025","unstructured":"Dhar D, Mm S, Parvin N, Dey T, Pal A, Pal PK (2025) Islands and Neurology: An Exploration into a Unique Association. Neuroscientist 31(4):336\u2013348. https:\/\/doi.org\/10.1177\/10738584241257927","journal-title":"Neuroscientist"},{"issue":"1","key":"946_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng709","volume":"29","author":"A Zimprich","year":"2001","unstructured":"Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M et al (2001) Mutations in the gene encoding \u025b-sarcoglycan cause myoclonus\u2013dystonia syndrome. Nat Genet 29(1):66\u201369. https:\/\/doi.org\/10.1038\/ng709","journal-title":"Nat Genet"},{"key":"946_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.parkreldis.2020.09.023","volume":"80","author":"MI Vanegas","year":"2020","unstructured":"Vanegas MI, Marc\u00e9-Grau A, Mart\u00ed-S\u00e1nchez L, Mellid S, Baide-Mairena H, Correa-Vela M et al (2020) Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome. Parkinsonism Relat Disord 80:165\u201374. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.023","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"946_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng1194-236","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M et al (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8(3):236\u201342. https:\/\/doi.org\/10.1038\/ng1194-236","journal-title":"Nat Genet"},{"issue":"3","key":"946_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s007020200026","volume":"109","author":"U M\u00fcller","year":"2002","unstructured":"M\u00fcller U, Steinberger D, Topka H (2002) Mutations of GCH1 in Dopa-responsive dystonia. J Neural Transm 109(3):321\u2013328. https:\/\/doi.org\/10.1007\/s007020200026","journal-title":"J Neural Transm"},{"issue":"11","key":"946_CR37","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00415-009-5198-z","volume":"256","author":"E L\u00f3pez-Laso","year":"2009","unstructured":"L\u00f3pez-Laso E, Ochoa-Sep\u00falveda JJ, Ochoa-Amor JJ, Bescansa-Heredero E, Camino-Le\u00f3n R, Gasc\u00f3n-Jim\u00e9nez FJ et al (2009) Segawa syndrome due to mutation Q89X in the GCH1 gene: a possible founder effect in C\u00f3rdoba (southern Spain). J Neurol 256(11):1816\u201324. https:\/\/doi.org\/10.1007\/s00415-009-5198-z","journal-title":"J Neurol"},{"key":"946_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/BF00225091","author":"B Ldecke","year":"1995","unstructured":"Ldecke B, Dworniczak B, Bartholom K (1995) A point mutation in the tyrosine hydroxylase gene associated with Segawa\u2019s syndrome. Hum Genet. https:\/\/doi.org\/10.1007\/BF00225091","journal-title":"Hum Genet"},{"issue":"4","key":"946_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.ejhg.5201986","volume":"16","author":"K Nuytemans","year":"2008","unstructured":"Nuytemans K, Rademakers R, Theuns J, Pals P, Engelborghs S, Pickut B et al (2008) Founder mutation p.Arg1441Cys in the leucine-rich repeat kinase 2 gene in Belgian Parkinson\u2019s disease patients. Eur J Hum Genet EJHG 16(4):471\u2013479. https:\/\/doi.org\/10.1038\/sj.ejhg.5201986 PubMed PMID: 18197194","journal-title":"Eur J Hum Genet EJHG"},{"issue":"6","key":"946_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/nmt-2023-0025","volume":"13","author":"H El Otmani","year":"2023","unstructured":"El Otmani H, Daghi M, Tahiri Jouti N, Lesage S (2023) An overview of the worldwide distribution of LRRK2 mutations in Parkinson\u2019s disease. Neurodegener Dis Manag 13(6):335\u201350. https:\/\/doi.org\/10.2217\/nmt-2023-0025","journal-title":"Neurodegener Dis Manag"},{"issue":"7","key":"946_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181335","volume":"12","author":"R Ben El Haj","year":"2017","unstructured":"Ben El Haj R, Salmi A, Regragui W, Moussa A, Bouslam N, Tibar H et al (2017) Evidence for prehistoric origins of the G2019S mutation in the North African Berber population. PLoS One 12(7):e0181335. https:\/\/doi.org\/10.1371\/journal.pone.0181335","journal-title":"PLoS One"},{"issue":"16","key":"946_CR42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1212\/01.wnl.0000277637.33328.d8","volume":"69","author":"A Orr-Urtreger","year":"2007","unstructured":"Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T et al (2007) The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 69(16):1595\u20131602. https:\/\/doi.org\/10.1212\/01.wnl.0000277637.33328.d8 PubMed PMID: 17938369","journal-title":"Neurology"},{"issue":"4","key":"946_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","volume":"15","author":"K Hasegawa","year":"2009","unstructured":"Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S (2009) Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord 15(4):300\u2013306. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.07.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 6","key":"946_CR44","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/brain\/awg136","volume":"126","author":"M Periquet","year":"2003","unstructured":"Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S et al (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 126(Pt 6):1271\u20138","journal-title":"Brain"},{"issue":"2","key":"946_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3940(02)00511-6","volume":"328","author":"E Mu\u00f1oz","year":"2002","unstructured":"Mu\u00f1oz E, Pastor P, Mart\u00ed MJ, Oliva R, Tolosa E (2002) A new mutation in the parkin gene in a patient with atypical autosomal recessive juvenile parkinsonism. Neurosci Lett 328(2):109\u2013111","journal-title":"Neurosci Lett"},{"issue":"6676","key":"946_CR46","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605\u2013608. https:\/\/doi.org\/10.1038\/33416","journal-title":"Nature"},{"issue":"5674","key":"946_CR47","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S et al (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304(5674):1158\u201360. https:\/\/doi.org\/10.1126\/science.1096284","journal-title":"Science"},{"issue":"19","key":"946_CR48","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 351(19):1972\u20131977 PubMed PMID: 15525722","journal-title":"N Engl J Med"},{"issue":"4","key":"946_CR49","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ana.410390412","volume":"39","author":"LG Goldfarb","year":"1996","unstructured":"Goldfarb LG, Vasconcelos O, Platonov FA, Lunkes A, Kipnis V, Kononova S et al (1996) Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol 39(4):500\u2013506 PubMed PMID: 8619528","journal-title":"Ann Neurol"},{"issue":"2","key":"946_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/brain\/94.2.359","volume":"94","author":"NH Wadia","year":"1971","unstructured":"Wadia NH, Swami RK, A NEW FORM OF HEREDO-FAMILIAL SPINOCEREBELLAR, DEGENERATION WITH SLOW EYE MOVEMENTS (NINE FAMILIES) (1971) Brain 94(2):359\u2013374. https:\/\/doi.org\/10.1093\/brain\/94.2.359","journal-title":"Brain"},{"issue":"2","key":"946_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neulet.2009.03.015","volume":"454","author":"L Vel\u00e1zquez P\u00e9rez","year":"2009","unstructured":"Vel\u00e1zquez P\u00e9rez L, S\u00e1nchez Cruz G, Santos Falc\u00f3n N, Almaguer Mederos LE, Escalona Batallan K, Rodr\u00edguez Labrada R et al (2009) Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin. Neurosci Lett 454(2):157\u2013160 PubMed PMID: 19429075","journal-title":"Neurosci Lett"},{"issue":"1","key":"946_CR52","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200225","volume":"11","author":"SM Pulst","year":"2025","unstructured":"Pulst SM (2025) Spinocerebellar ataxia type 2: a review and personal perspective. Neurol Genet 11(1):e200225. https:\/\/doi.org\/10.1212\/NXG.0000000000200225","journal-title":"Neurol Genet"},{"issue":"2","key":"946_CR53","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1086\/514867","volume":"61","author":"K Ishikawa","year":"1997","unstructured":"Ishikawa K, Tanaka H, Saito M, Ohkoshi N, Fujita T, Yoshizawa K et al (1997) Japanese Families with Autosomal Dominant Pure Cerebellar Ataxia Map to Chromosome 19p13.1-p13.2 and Are Strongly Associated with Mild CAG Expansions in the Spinocerebellar Ataxia Type 6 Gene in Chromosome 19p13.1. Am J Hum Genet 61(2):336\u2013346. https:\/\/doi.org\/10.1086\/514867","journal-title":"Am J Hum Genet"},{"issue":"1","key":"946_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0022-510x(01)00453-1","volume":"185","author":"M Mori","year":"2001","unstructured":"Mori M, Adachi Y, Kusumi M, Nakashima K (2001) Spinocerebellar ataxia type 6: founder effect in Western Japan. J Neurol Sci 185(1):43\u20137. https:\/\/doi.org\/10.1016\/s0022-510x(01)00453-1","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"946_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2015.04.053","volume":"354","author":"DC Smith","year":"2015","unstructured":"Smith DC, Atadzhanov M, Mwaba M, Greenberg LJ (2015) Evidence for a common founder effect amongst South African and Zambian individuals with spinocerebellar ataxia type 7. J Neurol Sci 354(1\u20132):75\u20138. https:\/\/doi.org\/10.1016\/j.jns.2015.04.053","journal-title":"J Neurol Sci"},{"issue":"12","key":"946_CR56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.ejhg.5200557","volume":"8","author":"J Jonasson","year":"2000","unstructured":"Jonasson J, Juvonen V, Sistonen P, Ignatius J, Johansson D, Bj\u00f6rck EJ et al (2000) Evidence for a common Spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia. Eur J Hum Genet 8(12):918\u201322. https:\/\/doi.org\/10.1038\/sj.ejhg.5200557","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"946_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10048-013-0387-4","volume":"15","author":"LE Garc\u00eda-Vel\u00e1zquez","year":"2014","unstructured":"Garc\u00eda-Vel\u00e1zquez LE, Canizales-Quinteros S, Romero-Hidalgo S, Ochoa-Morales A, Mart\u00ednez-Ruano L, M\u00e1rquez-Luna C et al (2014) Founder effect and ancestral origin of the spinocerebellar ataxia type 7 (SCA7) mutation in Mexican families. Neurogenetics 15(1):13\u20137. https:\/\/doi.org\/10.1007\/s10048-013-0387-4","journal-title":"Neurogenetics"},{"issue":"2","key":"946_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/79911","volume":"26","author":"T Matsuura","year":"2000","unstructured":"Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K et al (2000) Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 26(2):191\u2013194. https:\/\/doi.org\/10.1038\/79911","journal-title":"Nat Genet"},{"issue":"2","key":"946_CR59","doi-asserted-by":"publisher","first-page":"e4553","DOI":"10.1371\/journal.pone.0004553","volume":"4","author":"T Almeida","year":"2009","unstructured":"Almeida T, Alonso I, Martins S, Ramos EM, Azevedo L, Ohno K et al (2009) Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS ONE 4(2):e4553 PubMed PMID: 19234597","journal-title":"PLoS ONE"},{"issue":"5","key":"946_CR60","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1046\/j.1529-8817.2005.00173.x","volume":"69","author":"S Bahl","year":"2005","unstructured":"Bahl S, Virdi K, Mittal U, Sachdeva MP, Kalla AK, Holmes SE et al (2005) Evidence of a Common Founder for SCA12 in the Indian Population. Ann Hum Genet 69(5):528\u2013534. https:\/\/doi.org\/10.1046\/j.1529-8817.2005.00173.x","journal-title":"Ann Hum Genet"},{"issue":"2","key":"946_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/AOMD.AOMD_5_19","volume":"2","author":"D Kumar","year":"2019","unstructured":"Kumar D, Srivastava A, Faruq M, Gundluru V (2019) Spinocerebellar ataxia type 12: An update. Ann Mov Disord 2(2):48. https:\/\/doi.org\/10.4103\/AOMD.AOMD_5_19","journal-title":"Ann Mov Disord"},{"issue":"12","key":"946_CR62","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1212\/01.wnl.0000098883.79421.73","volume":"61","author":"BPC van de Warrenburg","year":"2003","unstructured":"van de Warrenburg BPC, Verbeek DS, Piersma SJ, Hennekam FAM, Pearson PL, Knoers NVAM et al (2003) Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology 61(12):1760\u20131765. https:\/\/doi.org\/10.1212\/01.wnl.0000098883.79421.73 PubMed PMID: 14694043","journal-title":"Neurology"},{"issue":"2","key":"946_CR63","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2207406","volume":"388","author":"D Pellerin","year":"2023","unstructured":"Pellerin D, Danzi MC, Wilke C, Renaud M, Fazal S, Dicaire MJ et al (2023) Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia. N Engl J Med 388(2):128\u2013141. https:\/\/doi.org\/10.1056\/NEJMoa2207406","journal-title":"N Engl J Med"},{"issue":"6","key":"946_CR64","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/acn3.70016","volume":"12","author":"A Cuillerier","year":"2025","unstructured":"Cuillerier A, Del Gobbo GF, Mackay L, Wall E, Couse M, McDonell LM et al (2025) FGF14 GAA Intronic Expansion in Unsolved Adult-Onset Ataxia in the Care4Rare Canada Consortium. Ann Clin Transl Neurol 12(6):1118\u20131125. https:\/\/doi.org\/10.1002\/acn3.70016","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"946_CR65","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10048-024-00770-y","volume":"25","author":"T De","year":"2024","unstructured":"De T, Sharma P, Upilli B, Vivekanand A, Bari S, Sonakar AK et al (2024) Spinocerebellar ataxia type 27B (SCA27B) in India: insights from a large cohort study suggest ancient origin. Neurogenetics 25(4):393\u2013403. https:\/\/doi.org\/10.1007\/s10048-024-00770-y PubMed PMID: 38976084","journal-title":"Neurogenetics"},{"issue":"3","key":"946_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s10038-022-01091-4","volume":"68","author":"K Ishikawa","year":"2023","unstructured":"Ishikawa K (2023) Spinocerebellar ataxia type 31 (SCA31). J Hum Genet 68(3):153\u20136. https:\/\/doi.org\/10.1038\/s10038-022-01091-4","journal-title":"J Hum Genet"},{"issue":"3","key":"946_CR67","doi-asserted-by":"publisher","first-page":"0111","DOI":"10.1007\/s100380300017","volume":"48","author":"M Li","year":"2003","unstructured":"Li M, Ishikawa K, Toru S, Tomimitsu H, Takashima M, Goto J et al (2003) Physical map and haplotype analysis of 16q-linked autosomal dominant cerebellar ataxia (ADCA) type III in Japan. J Hum Genet 48(3):0111\u20130118. https:\/\/doi.org\/10.1007\/s100380300017","journal-title":"J Hum Genet"},{"issue":"4","key":"946_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10048-004-0194-z","volume":"5","author":"R Hirano","year":"2004","unstructured":"Hirano R, Takashima H, Okubo R, Tajima K, Okamoto Y, Ishida S et al (2004) Fine mapping of 16q-linked autosomal dominant cerebellar ataxia type III in Japanese families. Neurogenetics 5(4):215\u2013221. https:\/\/doi.org\/10.1007\/s10048-004-0194-z","journal-title":"Neurogenetics"},{"issue":"5","key":"946_CR69","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ajhg.2009.09.019","volume":"85","author":"N Sato","year":"2009","unstructured":"Sato N, Amino T, Kobayashi K, Asakawa S, Ishiguro T, Tsunemi T et al (2009) Spinocerebellar ataxia type 31 is associated with inserted penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet 85(5):544\u2013557","journal-title":"Am J Hum Genet"},{"issue":"Pt 5","key":"946_CR70","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/brain\/aws069","volume":"135","author":"M Garc\u00eda-Murias","year":"2012","unstructured":"Garc\u00eda-Murias M, Quint\u00e1ns B, Arias M, Seixas AI, Cacheiro P, Tarr\u00edo R et al (2012) \u201cCosta da Morte\u201d ataxia is spinocerebellar ataxia 36: clinical and genetic characterization. Brain 135(Pt 5):1423\u201335. https:\/\/doi.org\/10.1093\/brain\/aws069","journal-title":"Brain"},{"issue":"6","key":"946_CR71","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.nrl.2014.11.005","volume":"32","author":"M Arias","year":"2017","unstructured":"Arias M, Garc\u00eda-Murias M, Sobrido MJ (2017) Spinocerebellar ataxia 36 (SCA36): \u00abCosta da Morte ataxia\u00bb. Neurol Barc Spain 32(6):386\u2013393. https:\/\/doi.org\/10.1016\/j.nrl.2014.11.005 PubMed PMID: 25593102","journal-title":"Neurol Barc Spain"},{"issue":"4","key":"946_CR72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1212\/WNL.0b013e318260436f","volume":"79","author":"Y Ikeda","year":"2012","unstructured":"Ikeda Y, Ohta Y, Kobayashi H, Okamoto M, Takamatsu K, Ota T et al (2012) Clinical features of SCA36: A novel spinocerebellar ataxia with motor neuron involvement (Asidan). Neurology 79(4):333\u2013341. https:\/\/doi.org\/10.1212\/WNL.0b013e318260436f","journal-title":"Neurology"},{"issue":"2","key":"946_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/cge.12344","volume":"87","author":"O Melamed","year":"2015","unstructured":"Melamed O, Behar DM, Bram C, Magal N, Pras E, Reznik-Wolf H et al (2015) Founder mutation for Huntington disease in Caucasus Jews. Clin Genet 87(2):167\u201372. https:\/\/doi.org\/10.1111\/cge.12344","journal-title":"Clin Genet"},{"issue":"6","key":"946_CR74","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington''''s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u201383","journal-title":"Cell"},{"issue":"7","key":"946_CR75","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.b.32332","volume":"168","author":"A Krause","year":"2015","unstructured":"Krause A, Mitchell C, Essop F, Tager S, Ndlovu B, Dubb A et al (2015) Junctophilin 3 (JPH3) expansion mutations causing Huntington disease-like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet B Neuropsychiatr Genet 168(7):573\u2013585. https:\/\/doi.org\/10.1002\/ajmg.b.32332 PubMed PMID: 26079385","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"946_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/ng0194-9","volume":"6","author":"R Koide","year":"1994","unstructured":"Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K et al (1994) Unstable expansion of CAG repeat in hereditary dentatorubral\u2013pallidoluysian atrophy (DRPLA). Nat Genet 6(1):9\u201313. https:\/\/doi.org\/10.1038\/ng0194-9","journal-title":"Nat Genet"},{"issue":"4","key":"946_CR77","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ng0894-521","volume":"7","author":"JR Burke","year":"1994","unstructured":"Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, Hulette C et al (1994) The Haw River Syndrome: Dentatorubropallidoluysian atrophy (DRPLA) in an African\u2013American family. Nat Genet 7(4):521\u2013524. https:\/\/doi.org\/10.1038\/ng0894-521","journal-title":"Nat Genet"},{"key":"946_CR78","doi-asserted-by":"publisher","unstructured":"Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F et al (1999) Molecular characterization of Wilson disease in the Sardinian population? Evidence of a founder effect. Hum Mutat 14(4):294\u2013303. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(199910)14:4%3C;294::AID-HUMU4%3E;3.0.CO;2-9","DOI":"10.1002\/(SICI)1098-1004(199910)14:4%3C;294::AID-HUMU4%3E;3.0.CO;2-9"},{"issue":"1","key":"946_CR79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10038-007-0218-2","volume":"53","author":"CM Mak","year":"2008","unstructured":"Mak CM, Lam CW, Tam S, Lai CL, Chan LY, Fan ST et al (2008) Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet 53(1):55\u201363. https:\/\/doi.org\/10.1007\/s10038-007-0218-2","journal-title":"J Hum Genet"},{"key":"946_CR80","unstructured":"Svetel M, Kozi\u0107 D, Stefanova E, Semnic R, Dragasevic N, Kosti\u0107 VS (2019) Pallidal T2 hypointensity in patients with pantothenate-kinase-associated neurodegeneration and a founder PANK2 mutation in the Roma\/Serbian population. Arch Biol Sci"},{"issue":"4","key":"946_CR81","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10048-005-0018-9","volume":"6","author":"P Rump","year":"2005","unstructured":"Rump P, Lemmink HH, Verschuuren-Bemelmans CC, Grootscholten PM, Fock JM, Hayflick SJ et al (2005) A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect. Neurogenetics 6(4):201\u2013207. https:\/\/doi.org\/10.1007\/s10048-005-0018-9","journal-title":"Neurogenetics"},{"issue":"1","key":"946_CR82","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/mds.28807","volume":"37","author":"F Magrinelli","year":"2022","unstructured":"Magrinelli F, Mehta S, Di Lazzaro G, Latorre A, Edwards MJ, Balint B et al (2022) Dissecting the phenotype and genotype of <sc>PLA2G6<\/sc>-related parkinsonism. Mov Disord 37(1):148\u201361. https:\/\/doi.org\/10.1002\/mds.28807","journal-title":"Mov Disord"},{"issue":"10","key":"946_CR83","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Gr\u00fcndemann J, Stiller B, Hampshire D, Cid LP et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38(10):1184\u201391. https:\/\/doi.org\/10.1038\/ng1884","journal-title":"Nat Genet"},{"issue":"4","key":"946_CR84","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ng571","volume":"28","author":"ARJ Curtis","year":"2001","unstructured":"Curtis ARJ, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF et al (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28(4):350\u2013354. https:\/\/doi.org\/10.1038\/ng571","journal-title":"Nat Genet"},{"issue":"6","key":"946_CR85","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ajhg.2008.10.018","volume":"83","author":"AM Alazami","year":"2008","unstructured":"Alazami AM, Al-Saif A, Al-Semari A, Bohlega S, Zlitni S, Alzahrani F et al (2008) Mutations in C2orf37, Encoding a Nucleolar Protein, Cause Hypogonadism, Alopecia, Diabetes Mellitus, Mental Retardation, and Extrapyramidal Syndrome. Am J Hum Genet 83(6):684\u2013691. https:\/\/doi.org\/10.1016\/j.ajhg.2008.10.018","journal-title":"Am J Hum Genet"},{"issue":"4","key":"946_CR86","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-019-0372-4","volume":"51","author":"A Cortese","year":"2019","unstructured":"Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY et al (2019) Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet 51(4):649\u2013658. https:\/\/doi.org\/10.1038\/s41588-019-0372-4","journal-title":"Nat Genet"},{"issue":"9","key":"946_CR87","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1093\/brain\/awaa203","volume":"143","author":"SJ Beecroft","year":"2020","unstructured":"Beecroft SJ, Cortese A, Sullivan R, Yau WY, Dyer Z, Wu TY et al (2020) A M\u0101ori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele. Brain 143(9):2673\u20132680. https:\/\/doi.org\/10.1093\/brain\/awaa203","journal-title":"Brain"},{"issue":"1","key":"946_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/mgme.1998.2693","volume":"64","author":"M Telatar","year":"1998","unstructured":"Telatar M, Wang S, Castellvi-Bel S, Tai LQ, Sheikhavandi S, Regueiro JR et al (1998) A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia. Mol Genet Metab 64(1):36\u201343. https:\/\/doi.org\/10.1006\/mgme.1998.2693","journal-title":"Mol Genet Metab"},{"issue":"2","key":"946_CR89","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/72769","volume":"24","author":"JC Engert","year":"2000","unstructured":"Engert JC, B\u00e9rub\u00e9 P, Mercier J, Dor\u00e9 C, Lepage P, Ge B et al (2000) ARSACS, a spastic ataxia common in northeastern Qu\u00e9bec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet 24(2):120\u2013125","journal-title":"Nat Genet"},{"issue":"2","key":"946_CR90","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10048-008-0118-4","volume":"9","author":"F Madia","year":"2008","unstructured":"Madia F, Striano P, Di Bonaventura C, de Falco A, de Falco FA, Manfredi M et al (2008) Benign adult familial myoclonic epilepsy (BAFME): evidence of an extended founder haplotype on chromosome 2p11.1-q12.2 in five Italian families. Neurogenetics 9(2):139\u201342. https:\/\/doi.org\/10.1007\/s10048-008-0118-4","journal-title":"Neurogenetics"},{"issue":"4","key":"946_CR91","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0497-393","volume":"15","author":"K Virtaneva","year":"1997","unstructured":"Virtaneva K, D\u2019Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G et al (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 15(4):393\u2013396. https:\/\/doi.org\/10.1038\/ng0497-393","journal-title":"Nat Genet"},{"issue":"2","key":"946_CR92","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng1001-189","volume":"29","author":"MC Moreira","year":"2001","unstructured":"Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T et al (2001) The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT\/Zn-finger protein aprataxin. Nat Genet 29(2):189\u2013193","journal-title":"Nat Genet"},{"issue":"12","key":"946_CR93","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/ng.1008","volume":"43","author":"WJ Chen","year":"2011","unstructured":"Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH et al (2011) Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 43(12):1252\u20131255. https:\/\/doi.org\/10.1038\/ng.1008","journal-title":"Nat Genet"},{"issue":"5","key":"946_CR94","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000193","volume":"3","author":"MJ Barrett","year":"2017","unstructured":"Barrett MJ, Williams ES, Chambers C, Dhamija R (2017) Autosomal recessive inheritance of ADCY5 -related generalized dystonia and myoclonus. Neurol Genet 3(5):193. https:\/\/doi.org\/10.1212\/NXG.0000000000000193","journal-title":"Neurol Genet"},{"issue":"1","key":"946_CR95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1086\/301931","volume":"63","author":"WL Greer","year":"1998","unstructured":"Greer WL, Riddell DC, Gillan TL, Girouard GS, Sparrow SM, Byers DM et al (1998) The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097\u2192T transversion in NPC1. Am J Hum Genet 63(1):52\u20134","journal-title":"Am J Hum Genet"},{"issue":"2","key":"946_CR96","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng0295-141","volume":"9","author":"K Ouahchi","year":"1995","unstructured":"Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R et al (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 9(2):141\u2013145","journal-title":"Nat Genet"},{"issue":"3","key":"946_CR97","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cge.14658","volume":"107","author":"S Biglari","year":"2025","unstructured":"Biglari S, Nikuei P, Mir A, Vahidnezhad H, Youssefian L, Moghaddam AS et al (2025) Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and In Silico Analysis. Clin Genet 107(3):366\u2013368. https:\/\/doi.org\/10.1111\/cge.14658 PubMed PMID: 39702880","journal-title":"Clin Genet"},{"issue":"9","key":"946_CR98","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/WNL.0000000000012466","volume":"97","author":"Y Su","year":"2021","unstructured":"Su Y, Fan L, Shi C, Wang T, Zheng H, Luo H et al (2021) Deciphering Neurodegenerative Diseases Using Long-Read Sequencing. Neurology 97(9):423\u2013433. https:\/\/doi.org\/10.1212\/WNL.0000000000012466","journal-title":"Neurology"},{"issue":"1","key":"946_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38766-1","volume":"14","author":"JD Wall","year":"2023","unstructured":"Wall JD, Sathirapongsasuti JF, Gupta R, Rasheed A, Venkatesan R, Belsare S et al (2023) South Asian medical cohorts reveal strong founder effects and high rates of homozygosity. Nat Commun 14(1):3377. https:\/\/doi.org\/10.1038\/s41467-023-38766-1","journal-title":"Nat Commun"},{"issue":"1","key":"946_CR100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11910-025-01414-w","volume":"25","author":"E Indelicato","year":"2025","unstructured":"Indelicato E, Zech M, Eberl A, Boesch S (2025) Insights on the Shared Genetic Landscape of Neurodevelopmental and Movement Disorders. Curr Neurol Neurosci Rep 25(1):24. https:\/\/doi.org\/10.1007\/s11910-025-01414-w","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"946_CR101","doi-asserted-by":"publisher","first-page":"192","DOI":"10.14802\/jmd.25256","volume":"19","author":"MK Farsana","year":"2026","unstructured":"Farsana MK, Holla VV, Dhar D, Gowda N, Padmanabha H, Muthusamy B et al (2026) Clinical, Radiological, and Therapeutic Profiles of Patients With DYT-TOR1A: A Single-Center Study in India and Literature Review of the Asian MDSGene Cohort. J Mov Disord 19(2):192\u2013198. https:\/\/doi.org\/10.14802\/jmd.25256","journal-title":"J Mov Disord"},{"key":"946_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70286","author":"M Bradley","year":"2026","unstructured":"Bradley M, Maher S, Espinoza-Vinces C, Gorman K, Lynch T, Walsh RA et al (2026) Pathogenic variants in the PRKRA gene can result in a rapid\u2010onset dystonia\u2010Parkinsonism\u2010like phenotype. Mov Disord. https:\/\/doi.org\/10.1002\/mds.70286","journal-title":"Mov Disord"},{"key":"946_CR103","doi-asserted-by":"publisher","unstructured":"Chin HL, Cheong KK, PRKRA-related Dystonia A Summary of Previously Reported Cases [Internet]. In Review; 2022 [cited 2026 Jun 14]. Available from: https:\/\/www.researchsquare.com\/article\/rs-2054215\/v1https:\/\/doi.org\/10.21203\/rs.3.rs-2054215\/v1","DOI":"10.21203\/rs.3.rs-2054215\/v1"},{"issue":"1","key":"946_CR104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.21206","volume":"22","author":"EK Tan","year":"2007","unstructured":"Tan EK, Skipper L, Tan L, Liu JJ (2007) LRRK2 G2019S founder haplotype in the Chinese population. Mov Disord Off J Mov Disord Soc 22(1):105\u2013107. https:\/\/doi.org\/10.1002\/mds.21206 PubMed PMID: 17083102","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"9","key":"946_CR105","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/mds.28112","volume":"35","author":"JM den Heijer","year":"2020","unstructured":"den Heijer JM, Cullen VC, Quadri M, Schmitz A, Hilt DC, Lansbury P et al (2020) A large-scale full GBA1 gene screening in Parkinson\u2019s disease in the Netherlands. Mov Disord 35(9):1667\u201374. https:\/\/doi.org\/10.1002\/mds.28112","journal-title":"Mov Disord"},{"issue":"3","key":"946_CR106","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10048-016-0481-5","volume":"17","author":"FA Platonov","year":"2016","unstructured":"Platonov FA, Tyryshkin K, Tikhonov DG, Neustroyeva TS, Sivtseva TM, Yakovleva NV et al (2016) Genetic fitness and selection intensity in a population affected with high-incidence spinocerebellar ataxia type 1. neurogenetics 17(3):179\u2013185. https:\/\/doi.org\/10.1007\/s10048-016-0481-5","journal-title":"neurogenetics"},{"issue":"2","key":"946_CR107","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/jmg.36.2.112","volume":"36","author":"K Mizushima","year":"1999","unstructured":"Mizushima K, Watanabe M, Kondo I, Okamoto K, Shizuka M, Abe K et al (1999) Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis: (CCG)1\u20132 polymorphism and contribution to founder effect. J Med Genet 36(2):112\u2013114 PubMed PMID: 10051008; PubMed Central PMCID: PMC1734293","journal-title":"J Med Genet"},{"issue":"2","key":"946_CR108","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1086\/318184","volume":"68","author":"C Gaspar","year":"2001","unstructured":"Gaspar C, Lopes-Cendes I, Hayes S, Goto J, Arvidsson K, Dias A et al (2001) Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet 68(2):523\u20138. https:\/\/doi.org\/10.1086\/318184","journal-title":"Am J Hum Genet"},{"issue":"2","key":"946_CR109","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cge.12114","volume":"85","author":"JJ Maga\u00f1a","year":"2014","unstructured":"Maga\u00f1a JJ, Tapia-Guerrero YS, Vel\u00e1zquez-P\u00e9rez L, Cerecedo-Zapata CM, Maldonado-Rodr\u00edguez M, Jano-Ito JS et al (2014) Analysis of CAG repeats in five SCA loci in Mexican population: epidemiological evidence of a SCA7 founder effect. Clin Genet 85(2):159\u201365. https:\/\/doi.org\/10.1111\/cge.12114","journal-title":"Clin Genet"},{"issue":"10","key":"946_CR110","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"The U.S.\u2013Venezuela Collaborative Research Project*, Wexler NS (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci 101(10):3498\u20133503. https:\/\/doi.org\/10.1073\/pnas.0308679101","journal-title":"Proc Natl Acad Sci"},{"key":"946_CR111","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-540-71693-8_5","volume-title":"Neuroacanthocytosis Syndromes II","author":"RL Margolis","year":"2008","unstructured":"Margolis RL, Rudnicki DD (2008) Huntington\u2019s Disease-Like 2. In: Walker RH, Saiki S, Danek A (eds) Neuroacanthocytosis Syndromes II. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 59\u201373. https:\/\/doi.org\/10.1007\/978-3-540-71693-8_5"},{"issue":"2","key":"946_CR112","doi-asserted-by":"publisher","first-page":"85","DOI":"10.17116\/jnevro202012002185","volume":"120","author":"GE Rudenskaya","year":"2020","unstructured":"Rudenskaya GE, Kadnikova VA, Ryzhkova OP (2020) [Spastic ataxia of Charlevoix-Saguenay: the first Russian case report and literature review]. Zh Nevrol Psikhiatr Im S S Korsakova 120(2):85\u201391. https:\/\/doi.org\/10.17116\/jnevro202012002185","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"10","key":"946_CR113","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1046\/j.1528-1157.2003.03703","volume":"44","author":"B Moulard","year":"2003","unstructured":"Moulard B, Darcel F, Mignard D, Jeanpierre M, Genton P, Cartault F et al (2003) FOunder effect in patients with Unverricht-Lundborg disease on reunion island. Epilepsia 44(10):1357\u20131360. https:\/\/doi.org\/10.1046\/j.1528-1157.2003.03703.x PubMed PMID: 14510831","journal-title":"Epilepsia"},{"issue":"3\u20134","key":"946_CR114","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/cge.13405","volume":"94","author":"JA Ruskey","year":"2018","unstructured":"Ruskey JA, Zhou S, Santiago R, Franche LA, Alam A, Ronci\u00e8re L et al (2018) The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies. Clin Genet 94(3\u20134):339\u201345. https:\/\/doi.org\/10.1111\/cge.13405","journal-title":"Clin Genet"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00946-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:32Z","timestamp":1790982152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-026-00946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1007\/s10048-026-00946-8","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study because it involved analysis of previously published literature and did not include human participants or identifiable patient data.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The review protocol was prospectively registered on the Open Science Framework (OSF; DOI:\n                      \n                      ).","order":3,"name":"Ethics","label":"Protocol registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"78"}}